文献速递乳腺外科围术期管理与 ERAS

双时点ICGA在经腋窝单孔内镜男性乳腺发育手术中的灌注引导:前瞻性探索性比较队列研究

Dual-time-point ICGA for perfusion-guided transaxillary single-port endoscopic gynecomastia surgery: a prospective exploratory comparative cohort study.
PubMed 文献 · Surg Endosc · 2026-10-09

该前瞻性探索性比较队列研究纳入88例接受经腋窝单孔内镜皮下腺体切除术的男性,其中43例接受双时点ICGA引导、45例未接受。ICGA组术后14天内灌注相关复合终点发生率为7.0%,非ICGA组为26.7%,绝对风险差为-19.7个百分点(95%CI -34.8至-3.9),OR为0.21(95%CI 0.05至0.79;P=0.022)。围术期恢复变量无显著差异,6个月时ICGA组胸部和乳头满意度更高,第二时点ICGA相对灌注值(RPV)较低与术后第14天局部组织改变相关,探索性预警阈值为26.0%。

要点

  • 双时点ICGA引导可减少经腋窝单孔内镜男性乳腺发育手术后14天内灌注相关组织改变。
  • ICGA组术后6个月胸部和乳头满意度更高,但瘢痕评价和心理功能无组间差异。
  • 第二时点ICGA的RPV 26.0%为探索性预警阈值,需外部验证。

核心结论

  • 标准化双时点ICGA方案在经腋窝单孔内镜男性乳腺发育手术中可行,并与更少的早期灌注相关组织改变相关,且未增加明显围术期负担。
  • 第二时点ICGA的26% RPV为探索性预警信号,需外部验证。

研究设计与样本

  • 前瞻性探索性比较队列研究,纳入88例接受经腋窝单孔内镜皮下腺体切除术的男性,ICGA组43例、非ICGA组45例。
  • ICGA组在胸大肌筋膜深面分离后及皮肤关闭后加压包扎前两个时点评估灌注,灌注分级指导术中调整和术后风险分层管理。

主要发现

  • 主要终点(术后14天内灌注相关复合终点)在ICGA组发生3/43例(7.0%),非ICGA组12/45例(26.7%),绝对风险差-19.7个百分点(95%CI -34.8至-3.9),OR 0.21(95%CI 0.05至0.79;P=0.022)。
  • 围术期恢复变量无显著差异。
  • 6个月时ICGA组胸部和乳头调整后满意度更高,瘢痕评价和心理功能无明确组间差异。
  • 第二时点ICGA RPV较低与术后第14天局部残留风险组织改变相关,探索性预警阈值为26.0%。

关键数值与推荐

  • 灌注相关复合终点:ICGA组7.0%(3/43) vs 非ICGA组26.7%(12/45),绝对风险差-19.7个百分点(95%CI -34.8至-3.9),OR 0.21(95%CI 0.05至0.79;P=0.022)。
  • 第二时点ICGA RPV 26.0%为探索性预警阈值。

临床怎么用

  • 在经腋窝单孔内镜男性乳腺发育手术中,可考虑采用双时点ICGA评估灌注以指导术中调整和术后风险分层管理。
  • 第二时点ICGA RPV低于26.0%时提示术后第14天局部组织改变风险,但该阈值仅为探索性,需外部验证后用于临床决策。

局限性

  • 本研究为探索性比较队列研究,非随机对照设计。
  • 26% RPV预警阈值需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated a standardized dual-time-point indocyanine green fluorescence angiography (ICGA) protocol in transaxillary single-port endoscopic surgery for gynecomastia, focusing on early perfusion-related outcomes, perioperative recovery, and patient-reported outcomes. METHODS: This prospective exploratory comparative cohort study included 88 men undergoing transaxillary single-port endoscopic subcutaneous glandular excision. Forty-three patients received ICGA and 45 did not. In the ICGA group, perfusion was assessed after deep dissection from the pectoralis major fascia and again after skin closure before compression dressing. Perfusion grading guided intraoperative adjustment and postoperative risk-stratified management. The primary outcome was a perfusion-related composite endpoint within 14 postoperative days. Secondary outcomes included perioperative variables, early complications, nipple sensation change, and 6-month BODY-Q scores. An exploratory observation point analysis assessed the association between second ICGA relative perfusion value (RPV) and postoperative day 14 local tissue changes. RESULTS: The primary endpoint occurred in 3 of 43 patients (7.0%) in the ICGA group and 12 of 45 patients (26.7%) in the non-ICGA group, corresponding to an absolute risk difference of - 19.7 percentage points (95% confidence interval, - 34.8 to - 3.9) and an odds ratio of 0.21 (95% confidence interval, 0.05 to 0.79; P = 0.022). Perioperative recovery variables did not differ significantly. At 6 months, adjusted satisfaction with chest and nipples was higher in the ICGA group, whereas scar appraisal and psychological function showed no clear between-group differences. Lower second ICGA RPV was associated with postoperative day 14 local residual risk tissue changes, with 26.0% identified as an exploratory warning threshold. CONCLUSIONS: A standardized dual-time-point ICGA protocol was feasible and was associated with fewer early perfusion-related tissue changes without evident perioperative burden. The 26% RPV value remains an exploratory warning signal requiring external validation.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wang C, Jiang H, Zhang X, et al. Dual-time-point ICGA for perfusion-guided transaxillary single-port endoscopic gynecomastia surgery: a prospective exploratory comparative cohort study. Surg Endosc. 2026. PMID: 42855512. doi:10.1007/s00464-026-13451-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。